Market Cap 10.54B
Revenue (ttm) 2.94B
Net Income (ttm) 537.87M
EPS (ttm) N/A
PE Ratio 19.16
Forward PE 19.08
Profit Margin 18.30%
Debt to Equity Ratio 0.00
Volume 6,038,700
Avg Vol 1,150,602
Day's Range N/A - N/A
Shares Out 135.25M
Stochastic %K 8%
Beta 1.00
Analysts Strong Sell
Price Target $110.08

Company Profile

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; intervention...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 930 1800
Address:
2560 General Armistead Avenue, Audubon, United States
StockMacroView
StockMacroView May. 7 at 9:05 PM
$GMED A fairly clean earnings + guidance beat setup. Q1 EPS came in at $1.12, beating by $0.20, with revenue at $759.85M, up 27% YoY and slightly above expectations. The more important shift is forward-looking: FY26 EPS guidance was raised to $4.70–$4.80 vs $4.47 consensus, while revenue guidance was maintained rather than cut. This kind of setup usually signals one thing — not just a strong quarter, but improving confidence in the full-year trajectory. Free sharing and subscription 👉 @StockMacroView.
1 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 8:31 PM
$GMED Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.92 up 67.27% YoY • Reported revenue of $759.85M up 27.04% YoY • Globus Medical reaffirms its full-year 2026 revenue guidance of $3.18B to $3.22B and updated non-GAAP diluted EPS guidance to $4.70 to $4.80, raised from $4.40 to $4.50.
0 · Reply
1truth2be3told
1truth2be3told May. 7 at 8:31 PM
$GMED If I were Globus CEO, this is golden opportunity to buy up ATEC, Pat Miles’ second company as did with his first company, Nuvasive. ATEC is at similar stage as Nuvasive but at much cheaper MC of $1B . Globus paid much more for NuVa.
0 · Reply
Estimize
Estimize May. 7 at 3:00 PM
$GMED reports after the close, Estimize Consensus +0.12 EPS and +27.78M Revs compared to WS http://www.estimize.com/gmed/fq1-2026?utm_conte
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 27 at 4:53 PM
$GMED Share Price: $94.28 Contract Selected: Dec 18, 2026 $95 Calls Buy Zone: $9.61 – $11.87 Target Zone: $17.90 – $21.88 Potential Upside: 76% ROI Time to Expiration: 234 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
G_krupins
G_krupins Apr. 26 at 1:48 PM
$GMED range bound forever. Alert at line if it decides to move
0 · Reply
OnTheGoTrades
OnTheGoTrades Apr. 24 at 8:33 PM
$GMED flirting with ATHs
0 · Reply
Doozio
Doozio Apr. 22 at 3:59 AM
$GMED huckleberries n $$$ patterns as it was always ONTO 🐒🍌🧠⏰♾️
0 · Reply
JFDI
JFDI Apr. 21 at 9:05 PM
0 · Reply
Realtrader77
Realtrader77 Apr. 20 at 1:57 PM
$GMED best company to bet on. Robotics / physical AI GROWTH for all musculoskeletal disorders. Well run 3b$ Arr and trades at 12b$ market cap which is cheap. It has close 700m$ cash. Zero debt. Well run and easy take over target. PT 170-200$.
0 · Reply
Latest News on GMED
Globus Medical reports Q1 EPS $1.12, consensus 92c

2026-05-07T23:09:57.000Z - 2 days ago

Globus Medical reports Q1 EPS $1.12, consensus 92c


Globus Medical Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 days ago

Globus Medical Earnings Call Transcript: Q1 2026


Globus Medical Reports First Quarter 2026 Results

May 7, 2026, 4:15 PM EDT - 2 days ago

Globus Medical Reports First Quarter 2026 Results


Globus Medical Announces Board Departure

Mar 23, 2026, 5:25 PM EDT - 6 weeks ago

Globus Medical Announces Board Departure


Globus Medical assumed with an Overweight at Wells Fargo

2026-03-18T10:30:14.000Z - 7 weeks ago

Globus Medical assumed with an Overweight at Wells Fargo


Globus Medical price target raised to $115 from $105 at Truist

2026-02-25T14:41:00.000Z - 2 months ago

Globus Medical price target raised to $115 from $105 at Truist


Globus Medical reports Q4 EPS $1.28, consensus 96c

2026-02-24T21:51:04.000Z - 2 months ago

Globus Medical reports Q4 EPS $1.28, consensus 96c


Globus Medical Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 2 months ago

Globus Medical Earnings Call Transcript: Q4 2025


Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Feb 24, 2026, 4:15 PM EST - 2 months ago

Globus Medical Reports Fourth Quarter and Full Year 2025 Results


Globus Medical upgraded to Buy from Hold at Needham

2026-01-30T11:51:18.000Z - 3 months ago

Globus Medical upgraded to Buy from Hold at Needham


Globus Medical initiated with a Buy at TD Cowen

2026-01-26T21:40:22.000Z - 3 months ago

Globus Medical initiated with a Buy at TD Cowen


Globus Medical sees FY25 revenue $2.936B, consensus $2.89B

2026-01-07T21:36:11.000Z - 4 months ago

Globus Medical sees FY25 revenue $2.936B, consensus $2.89B


Globus Medical Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 6 months ago

Globus Medical Earnings Call Transcript: Q3 2025


Globus Medical Reports Third Quarter 2025 Results

Nov 6, 2025, 4:15 PM EST - 6 months ago

Globus Medical Reports Third Quarter 2025 Results


Is Wall Street Underestimating Globus Medical Stock's Potential?

Oct 22, 2025, 11:25 AM EDT - 7 months ago

Is Wall Street Underestimating Globus Medical Stock's Potential?


Globus Medical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Globus Medical Earnings Call Transcript: Q2 2025


Globus Medical Reports Second Quarter 2025 Results

Aug 7, 2025, 4:15 PM EDT - 9 months ago

Globus Medical Reports Second Quarter 2025 Results


Medical, Inc. Company Investigated by the Portnoy Law Firm

May 13, 2025, 6:28 PM EDT - 1 year ago

Medical, Inc. Company Investigated by the Portnoy Law Firm


Globus Medical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Globus Medical Earnings Call Transcript: Q1 2025


Globus Medical Reports First Quarter 2025 Results

May 8, 2025, 4:15 PM EDT - 1 year ago

Globus Medical Reports First Quarter 2025 Results


Globus Medical completes acquisition of Nevro Corp.

Apr 3, 2025, 8:31 AM EDT - 1 year ago

Globus Medical completes acquisition of Nevro Corp.


Globus Medical Transcript: CG 2025 Musculoskeletal Conference

Mar 10, 2025, 7:30 PM EDT - 1 year ago

Globus Medical Transcript: CG 2025 Musculoskeletal Conference


Globus Medical Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Globus Medical Earnings Call Transcript: Q4 2024


Globus Medical Launches ExcelsiusHub™ Navigation System

Nov 22, 2024, 4:30 PM EST - 1 year ago

Globus Medical Launches ExcelsiusHub™ Navigation System


StockMacroView
StockMacroView May. 7 at 9:05 PM
$GMED A fairly clean earnings + guidance beat setup. Q1 EPS came in at $1.12, beating by $0.20, with revenue at $759.85M, up 27% YoY and slightly above expectations. The more important shift is forward-looking: FY26 EPS guidance was raised to $4.70–$4.80 vs $4.47 consensus, while revenue guidance was maintained rather than cut. This kind of setup usually signals one thing — not just a strong quarter, but improving confidence in the full-year trajectory. Free sharing and subscription 👉 @StockMacroView.
1 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 8:31 PM
$GMED Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.92 up 67.27% YoY • Reported revenue of $759.85M up 27.04% YoY • Globus Medical reaffirms its full-year 2026 revenue guidance of $3.18B to $3.22B and updated non-GAAP diluted EPS guidance to $4.70 to $4.80, raised from $4.40 to $4.50.
0 · Reply
1truth2be3told
1truth2be3told May. 7 at 8:31 PM
$GMED If I were Globus CEO, this is golden opportunity to buy up ATEC, Pat Miles’ second company as did with his first company, Nuvasive. ATEC is at similar stage as Nuvasive but at much cheaper MC of $1B . Globus paid much more for NuVa.
0 · Reply
Estimize
Estimize May. 7 at 3:00 PM
$GMED reports after the close, Estimize Consensus +0.12 EPS and +27.78M Revs compared to WS http://www.estimize.com/gmed/fq1-2026?utm_conte
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 27 at 4:53 PM
$GMED Share Price: $94.28 Contract Selected: Dec 18, 2026 $95 Calls Buy Zone: $9.61 – $11.87 Target Zone: $17.90 – $21.88 Potential Upside: 76% ROI Time to Expiration: 234 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
G_krupins
G_krupins Apr. 26 at 1:48 PM
$GMED range bound forever. Alert at line if it decides to move
0 · Reply
OnTheGoTrades
OnTheGoTrades Apr. 24 at 8:33 PM
$GMED flirting with ATHs
0 · Reply
Doozio
Doozio Apr. 22 at 3:59 AM
$GMED huckleberries n $$$ patterns as it was always ONTO 🐒🍌🧠⏰♾️
0 · Reply
JFDI
JFDI Apr. 21 at 9:05 PM
0 · Reply
Realtrader77
Realtrader77 Apr. 20 at 1:57 PM
$GMED best company to bet on. Robotics / physical AI GROWTH for all musculoskeletal disorders. Well run 3b$ Arr and trades at 12b$ market cap which is cheap. It has close 700m$ cash. Zero debt. Well run and easy take over target. PT 170-200$.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 16 at 12:09 AM
$GMED RSI: 69.21, MACD: 1.3905 Vol: 3.27, MA20: 88.52, MA50: 89.03 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Apr. 14 at 1:51 AM
$GMED 👀
1 · Reply
Armadilloman
Armadilloman Mar. 19 at 2:42 PM
$GMED this sad turd being turdy very turdy yet again.
0 · Reply
goldenmanchurian
goldenmanchurian Mar. 17 at 5:33 PM
$ARAY senior management should approach $GEHC $MDT $TMO $GMED to get bought out, for as low as $400MIL., i will vote yes!
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 2:57 PM
5 medical instrument stocks flashing serious short-term upside 👀 $ISRG $GMED $EW $ALC $IRMD are getting attention as AI tools, acquisitions, and new product pipelines fuel growth expectations — a combo that often sparks momentum in this space. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-teaser-36722&ADID=SYND_STOCKTWITS_TWEET_2_2881459_TEASER_36722
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 1:57 PM
Five medical instrument stocks with significant short-term potential! 🚀 🤖 $ISRG leads the charge with AI-driven innovations, boasting a Zacks Rank #1 and a short-term price target indicating a 26% increase from its last close, with an upside of up to 52%. 💼 $GMED strengthens its position with strategic mergers, a debt-free balance sheet, and a promising pipeline, marked by a Zacks Rank #1 and a short-term target of a 24.7% gain, with an upside of up to 40.1%. 💔 $EW is advancing its Structural Heart business, supported by a Zacks Rank #2 and a short-term price target increase of 14%, with a maximum upside of 30.5%. 👓 $ALC capitalizes on its Vision Care innovations, with a Zacks Rank #2 and a short-term target increase of 13.9%, with an upside of up to 36.8%. 🩺 $IRMD expands with MRI-compatible products, holding a Zacks Rank #2 and a forecasted 19.9% rise, with an upside of 20%. Explore the full growth story here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-body-36721&ADID=SYND_STOCKTWITS_TWEET_2_2881459_BODY_36721
0 · Reply
ZacksResearch
ZacksResearch Mar. 5 at 3:05 PM
$GMED quietly taking share — but don’t ignore the risks ⚖️ The company is gaining ground in musculoskeletal solutions with spine growth, rapid product launches, and strong cash. At the same time, macro headwinds and rising costs are real overhangs. Is this a durable growth story or a margin squeeze waiting to happen? Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2879182/is-this-the-right-time-to-add-globus-medical-stock-to-your-portfolio?cid=sm-stocktwits-2-2879182-teaser-36083&ADID=SYND_STOCKTWITS_TWEET_2_2879182_TEASER_36083
0 · Reply
ZacksResearch
ZacksResearch Mar. 5 at 2:05 PM
Is $GMED a hidden gem in the medical device sector? 🤔 Despite macroeconomic headwinds, this Zacks Rank #3 stock has gained 14.7% over the past year, outperforming its declining industry. With a solid 18.8% average earnings surprise and strong financial stability, Globus Medical is showing potential. Discover the full breakdown here 👉 https://www.zacks.com/stock/news/2879182/is-this-the-right-time-to-add-globus-medical-stock-to-your-portfolio?cid=sm-stocktwits-2-2879182-body-36056&ADID=SYND_STOCKTWITS_TWEET_2_2879182_BODY_36056
0 · Reply
smartkarma
smartkarma Mar. 4 at 5:05 PM
$GMED | Globus Medical: Is the Post-Deal Integration Machine Turning NuVasive and Nevro Into a Real Musculoskeletal Powerhouse? "Globus Medical's third-quarter 2025 results reflect a balanced blend of growth and strategic maneuvers, marked by notable financial and..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/globus-medical-is-the-post-deal-integration-machine-turning-nuvasive-and-nevro-into-a-real-musculoskeletal-powerhouse
0 · Reply
IN0V8
IN0V8 Feb. 26 at 4:16 PM
$GMED Wells Fargo raises target price to $104 from $98
0 · Reply
NorthStarStats
NorthStarStats Feb. 26 at 2:05 AM
I forgot to post yesterday's stocks. Hopefully they did well today: $PRME Score: 100, $GMED Score 100, $EDIT Score 100, $LRMR Score 100, $SGMO Score 100
0 · Reply